Anti-muscarinic autoantibodies and vagal modulation in Chagas disease: Positive allosteric modulators vs desensitization and downregulation of M2 cardiac acetylcholine receptors

International Journal of Cardiology

Volumn 123, Issue 3, 2008, Pages 328-329

  Dávila, Diego F ^a   Donis, Jose H ^a   Dávila, Leonardo A ^a   Odreman, Wilmer A ^a   de Bellabarba, Gabriela Arata ^a   Villarroel, Vanesa ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

Author keywords

Anti muscarinic autoanti bodies; Chagas; Parasympathetic; Vagal; Ventricular fuction

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; MUSCARINIC M2 RECEPTOR; RECEPTOR ANTIBODY;

ALLOSTERISM; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CHAGAS DISEASE; CHRONOTROPISM; DESENSITIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROTECTION; HEART RATE VARIABILITY; HUMAN; NEUROMODULATION; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SINUS NODE; VAGUS NERVE STIMULATION;

ALLOSTERIC REGULATION; AUTOANTIBODIES; AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL MARKERS; CHAGAS DISEASE; DOWN-REGULATION; FEMALE; HEART RATE; HUMANS; IMMUNIZATION; MALE; PROGNOSIS; RECEPTORS, CHOLINERGIC; RECEPTORS, MUSCARINIC; SENSITIVITY AND SPECIFICITY;

EID: 37349114849     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.176     Document Type: Article

References (21)

1. Fisher J.T., Vincent S.G., Gomeza J., Yamada M., and Weis J. Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors. FASEB J 18 (2004) 711-713
2. Chiale P.A., Ferrari L., Mahler E., et al. Differential profile and biochemical effects of antiautonomic membrane receptors autoantibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103 (2001) 1765-1777
3. Goin J.C., Leiros C.P., Borda E., and Sterin-Borda L. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J 11 (1977) 77-83
4. Goin J.C., Borda E., Auger S., Storino R., and Sterin-Borda L. Cardiac M2 muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia. Heart 82 (1999) 273-278
5. Sterin-Borda L., and Borda E. Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia. Neuroimmumodulation 917 (2000) 273-280
6. Peter J.C., Tugler J., Eftekhari J., Maurice D., Hoebeke J., and Roegel J.C. Effects on heart rate of an anti-M2 acetylcholine receptor immune response in mice. FASEB J 19 (2005) 943-949
7. Ribeiro D.F., Donis A., Diaz Gimenez L., Quintero-Hernandez C., Campos de Carvalho A., Texeira MM., Guedez V., Barros M., Lombardi F., and da Rocha M. Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease. Int J Cardiol 117 (2007) 59-63
8. Malik M., and Camm A.J. Components of heart rate variability-what they mean and what they really measure. Am J Cardiol 72 (1993) 821-822
9. Hedman A.E., Hartikainem J.E.K., Tahvanainen K.U.O., and Hakumaki M.O. The high frequency component of heart rate variability reflects cardiac modulation rather than parasympathetic "tone". Acta Physiol Scand 155 (1995) 267-273
10. Goldberg J.J., Kim Y.H., Ahmed M.W., and Kadish A.H. Effects of increases in parasympathetic tone on heart rate variability. J Cardiovasc Electrophysiol 7 (1996) 594-602
11. Goldberg J.J., Chapalli S., Tung R., Parker M.A., and Kadish A.H. Relationship of heart rate variability to parasympathetic effect. Circulation 103 (2001) 1977-1981
12. Decourt L.V., Sosa E.A., and Pilegi F. Electrophysiological studies in the indeterminate form of Chagas' disease. Arq Bras Cardiol 36 (1981) 227-234
13. Maciel B.C., Gallo Jr. L., Marin Neto J.A., Lima Filho E.C., and Martins L.E. Autonomic nervous system control of heart rate during dynamic exercise in normal man. Clin Sci 71 (1986) 457-460
14. Madariaga Galvis W., Dávila Spinetti D.F., Donis Hernandez J.H., Bellabarba G., Lemorvan C., and Torres A.M. Estimation of cardiac parasympathetic reserve by means of dynamic exercise in patients with acute myocardial infarction. Inst Cardiol Mex 68 (1998) 37-43
15. Rocha A.L., Lombardi F., da Costa Rocha M.O., et al. Chronotropic incompetence and abnormal modulation in ambulatory Chagas disease patients. Ann Noninvasive Electrocardiol 11 (2006) 3-11
16. Gallo Junior L., Morelo Filho J., Maciel B.C., Marin-Neto J.A., Martins L.E., and Lima Filho E.C. Functional evaluation of sympathetic and parasympathetic systems in Chagas' disease using dynamic exercise. Cardiovasc Res 21 (1987) 922-927
17. de Resende L.A., Molina R.J., Carneiro A.C., Ferreira L.A., da Silva V.J., Prata A., and Correia A. Cardiac autonomic function in chagasic elderly patients in an endemic area: A time and frequency domain approach. Autonomic Neurosci 131 (2007) 94-101
18. Chiali P.A., and Ferrari I. Autoantibodies in Chagas' cardiomyopathy and arrthymias. Autoimmunity 34 (2001) 205-210
19. Nevo U., Golding I., Neumann A.U., Schwartz M., and Akselrod M. Autoimmunity as an immune defense against degenerative processes: primary mathematical model illustrating the bright side of autoimmunity. J Theor Biol 227 (2004) 583-592
20. Dávila D.F., Santiago J.J., and Odreman W. Vagal dysfunction and the pathogenesis of chronic Chagas disease. Int J Cardiol 103 (2005) 227-229
21. Davila D.F., Donis J.H., Torres A., and Ferrer J.A. A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease. Int J Cardiol 96 (2004) 191-195